• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP MITROFLOW AORTIC PERICARDIAL HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP MITROFLOW AORTIC PERICARDIAL HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number DLA23
Device Problems Inadequacy of Device Shape and/or Size (1583); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Information (3190)
Event Date 09/27/2015
Event Type  Injury  
Manufacturer Narrative
As the device was not available for return, no device analysis was possible.Furthermore, there was no reported issue with the device according to the follow-up information received.The available information suggests that the initially implanted device was the incorrect size, since the replacement device was not the same size as the initially implanted device.As such, the event is likely attributable to mis-sizing, and is deemed to be not device-related.No further investigation is warranted at this time; however, if further information becomes available in the future, appropriate investigative actions will be taken.
 
Event Description
The manufacturer was notified of the following event via patient tracking: on (b)(6) 2015 two devices were implanted at the same location (dla23, sn (b)(4) and dla21, sn (b)(4)).There was no indication on the patient registration form of which device remained implanted.Additional information received upon follow-up indicated that the patient outcome was good, and there was no reported issue with the device.No further information was available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITROFLOW AORTIC PERICARDIAL HEART VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc V5J5M 1
CA  V5J5M1
Manufacturer (Section G)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc V5J5M 1
CA   V5J5M1
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc V5J5M-1
CA   V5J5M1
MDR Report Key7135110
MDR Text Key95391656
Report Number3004478276-2017-00221
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000177
UDI-Public(01)00896208000177(240)DLA23(17)200430
Combination Product (y/n)N
Reporter Country CodeCY
PMA/PMN Number
P060038
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 12/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date04/30/2020
Device Model NumberDLA23
Device Catalogue NumberDLA23
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/25/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/12/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age58 YR
-
-